Poster

Enhancing The Patient Experience For Self-Injection Systems

BD Noble

Patient self-injection for chronic disease treatments is on the rise. Due to the complexity of injectable treatment regimens, the disease management process and patients’ emotional responses to changes in their lives related to their disease, onboarding aids, such as reusable demonstration devices, are becoming an increasingly prevalent and vital part of the patient onboarding process.

Demonstrators replicate actual medication delivery systems without the needle or medicament and allow patients to learn how to use a specific device in order to improve familiarity, increase confidence and build adherent behaviors.

To assist pharmaceutical manufacturers during development and in preparation for launch, Noble and BD have established a collaborative development framework to support the BD UltraSafe™ passive needle guard product family, with a customizable demonstrator platform to serve manufacturers developing and launching drug delivery systems. Providing demonstrators to pharmaceutical companies to enhance their patient education programs is becoming more important.

VIEW THE POSTER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Biosimilar Development? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

BD Medical - Pharmaceutical Systems